Clinical Study Results
Research Sponsor: AstraZeneca
Drug Studied: Benralizumab
Study Purpose: This study was done to learn how benralizumab
works and about its safety in participants
with severe asthma
Protocol Number: D3250C00045
Thank you!
Thank you for taking part in the clinical study for the study drug benralizumab,
also called MEDI-563.
You and all of the participants helped researchers learn more about benralizumab to help
people with severe asthma that is not controlled well with treatments that are already available.
AstraZeneca sponsored this study and believes it is important to share the results of the study
with you and the public. An independent non-profit organization called CISCRP helped prepare
this summary of the study results for you. We hope it helps you understand and feel proud of
your important role in medical research.
If you participated in the study and have questions about the results, please speak with the
study doctor or staff at your study site.
1